Tonix CEO Dr. Seth Lederman said he thinks his company’s live virus platform could offer the long-lasting, transmission-blocking protection against COVID-19 that the mRNA vaccines so far haven’t been able to.
Support local nonprofit news
Tonix CEO Dr. Seth Lederman said he thinks his company’s live virus platform could offer the long-lasting, transmission-blocking protection against COVID-19 that the mRNA vaccines so far haven’t been able to.